About Digitalis, clinician-led software and AI

Potential becomes valuable through refinement.

The name comes from foxglove. The company comes from the same idea: powerful capability only becomes useful when it is understood, controlled and refined.

A plant with extraordinary potential.

Foxglove — Digitalis — had been used for centuries before its effects were studied systematically. It could help, and it could harm. The potential was obvious; the method was still to be found.

In the eighteenth century, physician and botanist William Withering documented the effects of foxglove preparations with unusual care for the time: observing what worked, what failed, how dose changed effect, and where toxicity appeared. His 1785 account helped move digitalis from an imprecise remedy towards a more controlled therapeutic intervention.

The lesson: value emerges through observation, evidence, control and iteration.

The principle

Refinement is what made digitalis valuable.

The company is built on the same idea. New technology arrives with enormous capability and very little context. We work out where it belongs, what should remain deterministic, what complexity can be removed, and what evidence is needed before a product deserves trust.

From health to software more broadly.

Digitalis began in healthcare, where poor product decisions carry real consequences and where safety, governance, interoperability and operational reality belong in the design from day one.

The same disciplines apply everywhere. A product should understand its environment. AI belongs where uncertainty is useful; deterministic code belongs where certainty is required. Architecture should carry only the complexity the product has earned. Delivery should create evidence as well as output.

Digitalis now applies that approach across software, AI and digital products.

Founder

Dr Todd Miller, MBBS, MPH, MBA (Health Services Management), CHIA

Dr Todd Miller is a medical doctor and certified health informatician who founded Digitalis. He has led clinical governance, AI clinical decision support, telehealth and product delivery for national digital health services, and builds software where safety and evidence carry real weight.

Bachelor of Medicine, Bachelor of Surgery (MBBS)
Master of Public Health
Master of Business Administration (Health Services Management)
Certified Health Informatician Australasia (CHIA)
Member, Australian Institute of Company Directors

Dr Todd Miller on LinkedIn · Professional profile at Digitalis Health

What we mean by refinement.

Observe

Understand the user, workflow, constraints and failure modes before choosing the technology.

Separate signal from noise

Find the capability that changes the outcome and focus the product around it.

Control complexity

Keep deterministic functions deterministic and add probabilistic systems only where they create value.

Refine with evidence

Use real delivery to learn what should be strengthened, simplified or removed next.

Digitalis at a glance

What Digitalis is: A clinician-led Australian software and AI company at digitalis.com.au.
What we do: AI product development, MCP server development, software development and digital product strategy.
How we use AI: Where interpretation and uncertain reasoning create value. Deterministic logic everywhere else.
Products we run: Hazards QLD (live on the App Store) and StartYear (in beta).
Founder: Dr Todd Miller, medical doctor and certified health informatician.
Digitalis Health: The founder's clinical and digital health practice, at digitalishealth.com.au.
Company: Digitalis Health Pty Ltd, ABN 84 689 650 888, trading as Digitalis.
Where we work: Across Australia, remote or embedded with your team.

Build what matters.

Tell us what you are trying to build, change or understand. A first conversation starts with the problem.

Start a conversation